INTERVENTIONAL FLASHLIGHT

DOI: 10.4244/EIJ-D-17-00824

Recovery of absolute coronary flow and resistance one week after percutaneous coronary intervention of a chronic totally occluded coronary artery using the novel RayFlow© infusion catheter

Daniëlle C.J. Keulards*, MD; Frederik M. Zimmermann, MD; Nico H.J. Pijls, MD, PhD; Koen Teeuwen, MD

A 59-year-old male was admitted to the Catharina Hospital with unstable angina. Coronary angiography showed a chronic total occlusion (CTO) of the right coronary artery (RCA) (Panel A), and a proximal subtotal stenosis of the ramus circumflex (RCx) and septal collaterals (Rentrop grade 1) from the left anterior descending (LAD) to the RCA (Panel D). After discussion in the Heart Team, we decided not to perform percutaneous coronary intervention (PCI) of the LAD due to diffuse disease, discovered during the hyperaemic pullback, and the patient was scheduled for PCI of the chronic occluded RCA. Using the new technique of thermodilution with a low rate of saline (RayFlow© infusion catheter [Hexacath Inc., Paris, France], and CoroFlow™ software [Coroventis, Uppsala, Sweden]), we measured absolute flow and resistance in the donor vessel (the LAD) before and after PCI of the CTO (Panel D, Panel E)1,2. Absolute flow in the LAD before PCI of the RCA was 256 ml/min, with a microvascular resistance of 231 Wood units (WU). Additionally, we measured flow and resistance in the RCA after successful treatment, being 161 ml/min and 370 WU, respectively (Panel B, Panel G). Staged PCI of the RCx was performed after one week and all measurements in the RCA and LAD were repeated (Panel C, Panel F, Panel H). The absolute flow in the RCA had increased now by 86% to 300 ml/min compared to one week previously, with a decrease in microvascular resistance of 33% to 243 WU. Blood flow in the LAD area had decreased to 215 ml/min, due to the decrease of perfusion territory (Panel F).

This case elegantly demonstrates how this method can be used in the cath lab to study recovery of flow after PCI of a CTO. It illustrates that the microvasculature distal to a CTO needs a number of days to recover and normalise.

Conflict of interest statement

The authors have no conflicts of interest to declare.

Volume 14 Number 5
Aug 3, 2018
Volume 14 Number 5
View full issue


Key metrics

Suggested by Cory

Clinical research

10.4244/EIJ-D-22-00118 Dec 2, 2022
Changes in coronary collateral function after successful chronic total occlusion percutaneous coronary intervention
Keulards D et al
free

Clinical Research

10.4244/EIJ-D-21-00702 Jul 22, 2022
Impact of percutaneous coronary intervention of chronic total occlusions on absolute perfusion in remote myocardium
de Winter R et al
free

Image – Interventional flashlight

10.4244/EIJ-D-19-00973 Apr 2, 2021
Relationship between fractional flow reserve value and the amount of subtended myocardium
Tsujimoto M et al
free

Editorial

10.4244/EIJ-E-22-00016 Jul 22, 2022
The myocardial perfusion paradigm: a missing link between patient selection and appropriateness of treatment
Mashayekhi K and Pyxaras S
free
Trending articles
200.45

State-of-the-Art

10.4244/EIJ-D-21-00089 Jun 11, 2021
Intracoronary optical coherence tomography: state of the art and future directions
Ali ZA et al
free
154.43

State-of-the-Art

10.4244/EIJ-D-22-00776 Apr 3, 2023
Computed tomographic angiography in coronary artery disease
Serruys PW et al
free
92.95

State-of-the-Art Review

10.4244/EIJ-D-20-01296 Aug 27, 2021
Management of cardiogenic shock
Thiele H et al
free
47.4

State-of-the-Art

10.4244/EIJ-D-24-00386 Feb 3, 2025
Mechanical circulatory support for complex, high-risk percutaneous coronary intervention
Ferro E et al
free
43.65

Clinical research

10.4244/EIJ-D-23-00590 Dec 4, 2023
Prognostic impact of cardiac damage staging classification in each aortic stenosis subtype undergoing TAVI
Nakase M et al
free
36.5

State-of-the-Art

10.4244/EIJ-D-23-00448 Jan 15, 2024
Coronary spasm and vasomotor dysfunction as a cause of MINOCA
Yaker ZS et al
free
34.75

State-of-the-Art

10.4244/EIJ-D-23-00606 Jan 1, 2024
Targeting inflammation in atherosclerosis: overview, strategy and directions
Waksman R et al
free
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 7.6
2023 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2024)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved